GlassScriptPhysician profile
Howard J Broder
NPI 1336361500
$168,203.06
in general payments reported to CMS, 2019-2025
25 companies · $1,511 in 2025
The $1,511 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $5,409 · 2021: $43K · 2022: $25K · 2023: $17K · 2024: $4,646 · 2025: $1,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,948 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,956 · Consulting Fee: $5,000 · Travel and Lodging: $2,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,948.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,956.25 |
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $2,921.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $73,112.06 | 2021-2025 | Corevalve Evolut R, Hawkone, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $71,049.01 | 2019-2020 | |
| Abbott Laboratories | $10,717.47 | 2019-2025 | Amplatzer Amulet, Cardiomems, Mitraclip |
| Edwards Lifesciences Corporation | $3,976.75 | 2019-2022 | |
| Abiomed | $3,434.92 | 2019-2025 | Impella |
| Shockwave Medical, INC | $2,085.94 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $1,125.91 | 2019 | |
| Philips North America LLC | $428.96 | 2019-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (Am7) Stellarex |
| W. L. Gore & Associates, INC. | $305.49 | 2022-2023 | Gore Cardioform Septal Occluder |
| Heartflow, INC. | $286.98 | 2022-2024 | |
| Cvrx, INC. | $246.38 | 2021-2024 | Barostim Neo System |
| Surmodics, INC. | $230.39 | 2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Astrazeneca Pharmaceuticals LP | $171.95 | 2022 | |
| Teleflex LLC | $151.67 | 2022 | |
| Penumbra, INC. | $142.85 | 2023 | Indigo System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $122.39 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $121.82 | 2022 | |
| Boston Scientific Corporation | $114.17 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $104.91 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.49 | 2022-2023 | Lifevest |
| Amgen INC. | $57.29 | 2023-2024 | Repatha |
| Bard Peripheral Vascular, INC. | $45.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.41 | 2024 | |
| Cardiovascular Systems INC. | $23.82 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Broder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.